TAVR Changed Valve Replacement; Anteris Says Longer-Living Patients Expose the Next Challenge

As transcatheter aortic valve replacement (TAVR) expands into patients who may live decades after treatment, the structural heart industry is being forced to confront what its first generation of valves was not built to answer: what happens when the patient outlives the implant?...